Development group | Validation group | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
AUROC | 95%CI | Cut-off pot | Specificity | Sensitivity | AUROC | 95%CI | Cut-off pot | Specificity | Sensitivity | |
Age | 0.633 | 0.627–0.638 | 40.500 | 0.511 | 0.717 | 0.637 | 0.629–0.646 | 40.500 | 0.512 | 0.724 |
ALT | 0.750 | 0.745–0.756 | 17.500 | 0.623 | 0.759 | 0.746 | 0.738–0.754 | 17.500 | 0.626 | 0.743 |
GGT | 0.772 | 0.768–0.777 | 22.500 | 0.639 | 0.792 | 0.772 | 0.765–0.780 | 23.500 | 0.672 | 0.757 |
FPG | 0.653 | 0.646–0.659 | 5.195 | 0.615 | 0.610 | 0.651 | 0.641–0.661 | 5.225 | 0.640 | 0.578 |
ALB | 0.558 | 0.551–0.564 | 44.650 | 0.517 | 0.573 | 0.556 | 0.546–0.566 | 44.650 | 0.523 | 0.561 |
eGFR | 0.562 | 0.556–0.569 | 67.165 | 0.479 | 0.625 | 0.577 | 0.567–0.587 | 64.485 | 0.569 | 0.554 |
DBIL | 0.516 | 0.509–0.523 | 2.150 | 0.676 | 0.359 | 0.530 | 0.519–0.540 | 1.850 | 0.547 | 0.508 |
UA | 0.716 | 0.710–0.721 | 295.500 | 0.609 | 0.716 | 0.717 | 0.708–0.725 | 291.500 | 0.589 | 0.736 |
LDL-c, | 0.605 | 0.599–0.612 | 2.375 | 0.5740 | 0.591 | 0.604 | 0.594–0.614 | 2.385 | 0.584 | 0.579 |
BMI | 0.802 | 0.798–0.807 | 22.335 | 0.647 | 0.826 | 0.808 | 0.801–0.814 | 22.285 | 0.645 | 0.836 |
AIP | 0.803 | 0.798–0.808 | 0.005 | 0.715 | 0.752 | 0.802 | 0.795–0.810 | 0.025 | 0.735 | 0.733 |